Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

Please provide your email address to receive an email when new articles are posted on . The COVID-19 pandemic created new barriers for colorectal cancer screening. However, fecal occult blood tests ...

Is it time for you to begin screening for colorectal cancer? Screening looks for signs of cancer in someone who doesn’t have any symptoms. The idea is that by catching cancer early, before it spreads, ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

A new study conducted in the UK and published in Gut found blood detected in stool is associated with an increased risk of death from a wide range of causes, not just colorectal cancer. The ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

Although European controlled trials of screening with a nonrehydrated guaiac-based fecal occult blood test (gFOBT) have shown it reduces colorectal cancer (CRC) deaths, real-world results could differ ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Patients with acute coronary syndrome had similar outcomes for all-cause mortality and bleeding ...

Q: If a test showed blood in the stool, could this be caused by something eaten the day before? -- T.M., Lockport, N.Y. A: Bleeding in the gastrointestinal tract can be caused by something as minor as ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

PHOENIX – An Arizona company has a new colon cancer blood test on the market that sounds like an enticing alternative to the oft-dreaded colonoscopy. The $170 blood test, called BeScreened-CRC, was ...